Targeting Mitochondrial Integrity as a New Senolytic Strategy
Eliska Vacurova, Edita Vlachova, Jan Stursa, Klara Bohacova, Tereza Havrlantova, Vojtech Skop, Barbora Judita Kasperova, Lukas Werner, Jiri Neuzil, Martin Haluzik, Sona Stemberkova Hubackova · 2025
Read Targeting Mitochondrial Integrity as a New Senolytic Strategy by Eliska Vacurova, Edita Vlachova, Jan Stursa, Klara Bohacova, Tereza Havrlantova, Vojtech Skop, Barbora Judita Kasperova, Lukas Werner, Jiri Neuzil, Martin Haluzik, Sona Stemberkova Hubackova (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12539531.txt.
Description
Senescent cells, worn out cells that refuse to die, pile up with age and drive disease, so drugs that clear them are prized. Eliska Vacurova and ten co-authors steer an old drug, tamoxifen, into the power plants of such cells in 2024 by attaching chemical anchors that mitochondria attract. The targeted drug then breaks the power plant's workings from inside.
Breathing chains stall, one key complex stops, and the cells die by ferroptosis, an iron driven death. Tissues in treated animals read as rejuvenated in the study's measures. The authors present mitochondrial sabotage as a general way to clear senescent cells. They suggest it could extend healthy years if it survives translation to people.
Catalog record
| CREATOR | Eliska Vacurova, Edita Vlachova, Jan Stursa, Klara Bohacova, Tereza Havrlantova, Vojtech Skop, Barbora Judita Kasperova, Lukas Werner, Jiri Neuzil, Martin Haluzik, Sona Stemberkova Hubackova |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |